KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43 | -32.8% | 31,814 | -10.5% | 0.00% | 0.0% |
| Q2 2023 | $64 | -58.2% | 35,559 | -9.5% | 0.00% | -75.0% |
| Q1 2023 | $153 | +86.6% | 39,312 | +62.9% | 0.00% | +100.0% |
| Q4 2022 | $82 | -99.9% | 24,129 | -2.4% | 0.00% | -50.0% |
| Q3 2022 | $135,000 | +17.4% | 24,725 | -3.1% | 0.00% | +33.3% |
| Q2 2022 | $115,000 | -43.9% | 25,522 | -8.5% | 0.00% | -40.0% |
| Q1 2022 | $205,000 | +6.8% | 27,878 | -6.7% | 0.01% | +25.0% |
| Q4 2021 | $192,000 | -3.0% | 29,883 | -12.4% | 0.00% | 0.0% |
| Q3 2021 | $198,000 | -42.4% | 34,099 | +2.3% | 0.00% | -50.0% |
| Q2 2021 | $344,000 | +1.8% | 33,337 | +3.7% | 0.01% | +14.3% |
| Q1 2021 | $338,000 | -12.9% | 32,143 | +28.1% | 0.01% | 0.0% |
| Q4 2020 | $388,000 | +20.1% | 25,096 | +13.4% | 0.01% | -22.2% |
| Q3 2020 | $323,000 | +58.3% | 22,139 | +108.8% | 0.01% | +12.5% |
| Q1 2020 | $204,000 | -29.2% | 10,604 | -29.3% | 0.01% | +60.0% |
| Q4 2019 | $288,000 | +19.5% | 15,000 | -40.0% | 0.01% | 0.0% |
| Q3 2019 | $241,000 | +60.7% | 25,000 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $150,000 | +2.7% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $146,000 | -37.6% | 25,000 | 0.0% | 0.00% | -60.0% |
| Q4 2018 | $234,000 | -31.6% | 25,000 | +24.4% | 0.01% | +11.1% |
| Q3 2018 | $342,000 | +0.6% | 20,095 | +0.5% | 0.01% | +12.5% |
| Q2 2018 | $340,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |